Logo image of BSL.DE

BASLER AG (BSL.DE) Stock Fundamental Analysis

FRA:BSL - Deutsche Boerse Ag - DE0005102008 - Common Stock - Currency: EUR

9.235  -0.01 (-0.05%)

Fundamental Rating

4

BSL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 49 industry peers in the Electronic Equipment, Instruments & Components industry. While BSL seems to be doing ok healthwise, there are quite some concerns on its profitability. BSL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BSL has reported negative net income.
BSL had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BSL reported negative net income in multiple years.
BSL had a positive operating cash flow in each of the past 5 years.
BSL.DE Yearly Net Income VS EBIT VS OCF VS FCFBSL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

The Return On Assets of BSL (-2.18%) is comparable to the rest of the industry.
BSL has a Return On Equity (-3.94%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.18%
ROE -3.94%
ROIC N/A
ROA(3y)-1.08%
ROA(5y)2.8%
ROE(3y)-1.96%
ROE(5y)4.7%
ROIC(3y)N/A
ROIC(5y)N/A
BSL.DE Yearly ROA, ROE, ROICBSL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

BSL's Gross Margin of 46.70% is fine compared to the rest of the industry. BSL outperforms 67.35% of its industry peers.
BSL's Gross Margin has declined in the last couple of years.
BSL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.66%
GM growth 5Y-2.2%
BSL.DE Yearly Profit, Operating, Gross MarginsBSL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

BSL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BSL remains at a similar level compared to 1 year ago.
BSL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BSL has been reduced compared to a year ago.
BSL.DE Yearly Shares OutstandingBSL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BSL.DE Yearly Total Debt VS Total AssetsBSL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.40 indicates that BSL is not in any danger for bankruptcy at the moment.
BSL's Altman-Z score of 3.40 is fine compared to the rest of the industry. BSL outperforms 77.55% of its industry peers.
The Debt to FCF ratio of BSL is 11.16, which is on the high side as it means it would take BSL, 11.16 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 11.16, BSL perfoms like the industry average, outperforming 46.94% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that BSL is not too dependend on debt financing.
The Debt to Equity ratio of BSL (0.45) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 11.16
Altman-Z 3.4
ROIC/WACCN/A
WACC5.99%
BSL.DE Yearly LT Debt VS Equity VS FCFBSL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.38 indicates that BSL has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.38, BSL is in the better half of the industry, outperforming 77.55% of the companies in the same industry.
A Quick Ratio of 1.56 indicates that BSL should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.56, BSL is in the better half of the industry, outperforming 75.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 1.56
BSL.DE Yearly Current Assets VS Current LiabilitesBSL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

BSL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.39%, which is quite impressive.
The Revenue has been growing slightly by 5.14% in the past year.
BSL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.74% yearly.
EPS 1Y (TTM)67.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%222.1%
Revenue 1Y (TTM)5.14%
Revenue growth 3Y-4.88%
Revenue growth 5Y2.74%
Sales Q2Q%33.52%

3.2 Future

Based on estimates for the next years, BSL will show a very strong growth in Earnings Per Share. The EPS will grow by 105.85% on average per year.
BSL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.24% yearly.
EPS Next Y244.44%
EPS Next 2Y153.13%
EPS Next 3Y105.85%
EPS Next 5YN/A
Revenue Next Year5.55%
Revenue Next 2Y9.83%
Revenue Next 3Y10.7%
Revenue Next 5Y13.24%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BSL.DE Yearly Revenue VS EstimatesBSL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
BSL.DE Yearly EPS VS EstimatesBSL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BSL. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 23.05, which indicates a rather expensive current valuation of BSL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BSL is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of BSL to the average of the S&P500 Index (22.15), we can say BSL is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 23.05
BSL.DE Price Earnings VS Forward Price EarningsBSL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

BSL's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as BSL.
Industry RankSector Rank
P/FCF 47.06
EV/EBITDA 17.81
BSL.DE Per share dataBSL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

BSL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BSL's earnings are expected to grow with 105.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y153.13%
EPS Next 3Y105.85%

2

5. Dividend

5.1 Amount

BSL has a Yearly Dividend Yield of 1.52%.
Compared to an average industry Dividend Yield of 2.97, BSL has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.38, BSL is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.52%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BSL.DE Yearly Dividends per shareBSL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 0.5 1 1.5

5.3 Sustainability

DP0%
EPS Next 2Y153.13%
EPS Next 3Y105.85%
BSL.DE Yearly Income VS Free CF VS DividendBSL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

BASLER AG

FRA:BSL (6/2/2025, 5:24:44 PM)

9.235

-0.01 (-0.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-08 2025-05-08
Earnings (Next)08-07 2025-08-07
Inst Owners25.53%
Inst Owner ChangeN/A
Ins Owners6.63%
Ins Owner ChangeN/A
Market Cap290.90M
Analysts76
Price Target15.03 (62.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.52%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.61%
PT rev (3m)5.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-18.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.28%
Revenue NY rev (3m)2.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.05
P/S 1.46
P/FCF 47.06
P/OCF 17.96
P/B 2.26
P/tB 7.6
EV/EBITDA 17.81
EPS(TTM)-0.17
EYN/A
EPS(NY)0.4
Fwd EY4.34%
FCF(TTM)0.2
FCFY2.12%
OCF(TTM)0.51
OCFY5.57%
SpS6.34
BVpS4.09
TBVpS1.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.18%
ROE -3.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.7%
FCFM 3.1%
ROA(3y)-1.08%
ROA(5y)2.8%
ROE(3y)-1.96%
ROE(5y)4.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.66%
GM growth 5Y-2.2%
F-Score6
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 11.16
Debt/EBITDA 3.05
Cap/Depr 52.06%
Cap/Sales 5.02%
Interest Coverage N/A
Cash Conversion 84.72%
Profit Quality N/A
Current Ratio 2.38
Quick Ratio 1.56
Altman-Z 3.4
F-Score6
WACC5.99%
ROIC/WACCN/A
Cap/Depr(3y)94.94%
Cap/Depr(5y)97.08%
Cap/Sales(3y)7.69%
Cap/Sales(5y)7.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%222.1%
EPS Next Y244.44%
EPS Next 2Y153.13%
EPS Next 3Y105.85%
EPS Next 5YN/A
Revenue 1Y (TTM)5.14%
Revenue growth 3Y-4.88%
Revenue growth 5Y2.74%
Sales Q2Q%33.52%
Revenue Next Year5.55%
Revenue Next 2Y9.83%
Revenue Next 3Y10.7%
Revenue Next 5Y13.24%
EBIT growth 1Y99.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year373.81%
EBIT Next 3Y96.72%
EBIT Next 5YN/A
FCF growth 1Y148.05%
FCF growth 3Y-20.46%
FCF growth 5YN/A
OCF growth 1Y13.77%
OCF growth 3Y-16.7%
OCF growth 5Y-9.96%